How do I write a Continuous Renal Replacement Therapy (CRRT) order for a patient with fluid overload, on pressors, hyperkalemia, hyponatremia, and metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CRRT Order for a Fluid Overloaded Patient on Pressors with Electrolyte Abnormalities

For a patient with fluid overload on pressors with hyperkalemia (K+ 5.5 mmol/L), hyponatremia (Na+ 125 mmol/L), and metabolic acidosis (bicarbonate 19 mmol/L), continuous venovenous hemodiafiltration (CVVHDF) with a potassium-free replacement solution and sodium bicarbonate supplementation is the most appropriate CRRT modality.

Patient Assessment and CRRT Indication

  • The patient has multiple indications for CRRT: fluid overload, hemodynamic instability (on pressors), hyperkalemia, hyponatremia, and metabolic acidosis 1
  • Continuous RRT is preferred over intermittent hemodialysis in hemodynamically unstable patients on vasopressors 1
  • Fluid overload is associated with increased morbidity and mortality in critically ill patients 2

CRRT Order Components

1. Access and Equipment

  • Use an uncuffed non-tunneled dialysis catheter of appropriate length and gauge 1
  • First choice for site: right internal jugular vein or femoral vein (femoral site is inferior in patients with increased body mass) 1
  • Second choice: left jugular vein followed by subclavian vein 1

2. CRRT Modality

  • CVVHDF (Continuous Venovenous Hemodiafiltration) is appropriate for this patient 1
  • Provides both diffusive and convective clearance for better management of electrolyte abnormalities and fluid removal 1

3. Fluid Removal Goals

  • Set ultrafiltration rate based on fluid overload status, typically 100-300 mL/hr 2
  • Target negative fluid balance of 1-2 L/day depending on severity of fluid overload 2
  • Monitor hemodynamic parameters closely during fluid removal (blood pressure, heart rate, vasopressor requirements) 1

4. Replacement Solution

  • Use potassium-free replacement solution (0 mEq/L K+) to address hyperkalemia 1
  • Sodium concentration of 140-145 mEq/L to correct hyponatremia 1
  • Bicarbonate-based solution to address metabolic acidosis 1
  • Total replacement fluid rate: 20-25 mL/kg/hr 1

5. Dialysate Solution

  • Potassium-free dialysate (0 mEq/L K+) 1
  • Sodium concentration of 140-145 mEq/L 1
  • Bicarbonate concentration of 35 mEq/L to correct metabolic acidosis 1
  • Dialysate flow rate: 15-20 mL/kg/hr 1

6. Anticoagulation

  • Regional citrate anticoagulation is preferred if no contraindications exist 1
  • Alternative: heparin protocol with initial bolus of 15-25 units/kg followed by 5-10 units/kg/hr continuous infusion 1
  • For patients with high bleeding risk, consider no anticoagulation with periodic saline flushes 1

7. Monitoring Parameters

  • Hourly monitoring of vital signs, including blood pressure and heart rate 1
  • Monitor fluid balance every 1-2 hours 2
  • Check electrolytes (Na+, K+, Ca2+, Mg2+, phosphate) every 6 hours initially, then every 12 hours when stable 1
  • Monitor acid-base status with arterial blood gases every 6-12 hours 1
  • Continuous central venous pressure monitoring if available 1
  • Target urine output >0.5 mL/kg/hr 1

Special Considerations for This Patient

Hyperkalemia Management (K+ 5.5 mmol/L)

  • Use potassium-free replacement and dialysate solutions 1
  • Consider additional measures if severe hyperkalemia present (calcium gluconate, insulin/glucose, albuterol) 3
  • Recheck potassium levels every 4-6 hours initially 3

Hyponatremia Correction (Na+ 125 mmol/L)

  • Use replacement solution with sodium 140-145 mEq/L 1
  • Correct sodium gradually to avoid rapid changes 1
  • The induced change in serum osmolality should not exceed 3 mOsm/kg/hr 1
  • Monitor for neurological changes during sodium correction 1

Metabolic Acidosis Management (Bicarbonate 19 mmol/L)

  • Use bicarbonate-based replacement solution 1
  • Dialysate with bicarbonate concentration of 35 mEq/L 1
  • Monitor acid-base status with arterial blood gases 1

Hemodynamic Support

  • Adjust ultrafiltration rate based on hemodynamic response 1
  • Consider reducing ultrafiltration rate if blood pressure decreases or vasopressor requirements increase 1
  • Fluid removal should be judged by hemodynamic monitoring (improvement in blood pressure), measurement of fluid input/output, and clinical examination 1

Sample CRRT Order

CRRT Order:
- Modality: CVVHDF
- Access: Right internal jugular vein, 13.5 Fr dialysis catheter
- Blood flow rate: 150-200 mL/min
- Replacement fluid: Potassium-free (0 mEq/L K+), Na+ 140 mEq/L, bicarbonate-based
- Replacement fluid rate: 25 mL/kg/hr (pre-filter)
- Dialysate: Potassium-free (0 mEq/L K+), Na+ 140 mEq/L, bicarbonate 35 mEq/L
- Dialysate flow rate: 20 mL/kg/hr
- Ultrafiltration goal: 200 mL/hr (adjust based on hemodynamic tolerance)
- Net fluid removal goal: 1-2 L/day
- Anticoagulation: Regional citrate protocol
- Labs: Electrolytes, BUN, Cr, Ca2+, Mg2+, phosphate q6h initially, then q12h when stable
- ABG: q6h initially, then q12h when stable
- Continuous monitoring: Vital signs, fluid balance, vasopressor requirements

Pitfalls to Avoid

  • Avoid rapid correction of hyponatremia (>8 mEq/L/day) to prevent osmotic demyelination syndrome 1
  • Avoid excessive ultrafiltration that could worsen hypotension and increase vasopressor requirements 1
  • Monitor for citrate toxicity if using regional citrate anticoagulation (check ionized calcium) 1
  • Be cautious with fluid removal in patients with cardiac dysfunction to prevent hemodynamic instability 1
  • Adjust CRRT parameters based on the patient's clinical response rather than adhering to fixed protocols 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyperkalemia treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.